Pharmacological treatment of Parkinson disease: a review.

@article{Connolly2014PharmacologicalTO,
  title={Pharmacological treatment of Parkinson disease: a review.},
  author={Barbara S. Connolly and Anthony E. Lang},
  journal={JAMA},
  year={2014},
  volume={311 16},
  pages={
          1670-83
        }
}
  • Barbara S. Connolly, Anthony E. Lang
  • Published 2014
  • Medicine
  • JAMA
  • IMPORTANCE Parkinson disease is the second most common neurodegenerative disease worldwide. [...] Key MethodEVIDENCE REVIEW References were identified using searches of PubMed between January 1985 and February 2014 for English-language human studies and the full database of the Cochrane Library. The classification of studies by quality (classes I-IV) was assessed using the levels of evidence guidelines from the American Academy of Neurology and the highest-quality data for each topic. Expand Abstract

    Paper Mentions

    OBSERVATIONAL CLINICAL TRIAL
    The purpose of this study is to evaluate how safinamide, rasagiline and other SoC drugs are associated with the quality of life of PD patients by means of the Parkinson's Disease… Expand
    ConditionsParkinson's Disease
    INTERVENTIONAL CLINICAL TRIAL
    The study will look into the changes of Deep Brain Stimulation (DBS) measured impedances in patients of Parkinson disease (PD) as a function of their functional state (lying, sitting… Expand
    ConditionsParkinson Disease
    InterventionOther

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 586 CITATIONS, ESTIMATED 56% COVERAGE

    Pharmacological Treatment in Parkinson’s Disease

    VIEW 7 EXCERPTS
    HIGHLY INFLUENCED

    Treating the Motor Symptoms of Parkinson Disease.

    VIEW 1 EXCERPT
    CITES BACKGROUND

    Treatment of Older Parkinson's Disease.

    VIEW 1 EXCERPT
    CITES BACKGROUND

    Update on the treatment of Parkinson’s disease psychosis: role of pimavanserin

    VIEW 2 EXCERPTS
    CITES BACKGROUND

    A Stage-Based Approach to Therapy in Parkinson’s Disease

    VIEW 2 EXCERPTS
    CITES BACKGROUND

    FILTER CITATIONS BY YEAR

    2012
    2020

    CITATION STATISTICS

    • 35 Highly Influenced Citations

    • Averaged 101 Citations per year from 2018 through 2020

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 141 REFERENCES

    Impact of standard of care for psychosis in Parkinson disease

    Management of hallucinations and psychosis in Parkinson's disease.